Drug recall · August 24, 2022
Zynrelef recall
Why: Defective Delivery System: An incorrect 10 mL (12 mL) Luer (slip) syringe packaged in one lot of Zynrelef 400 mg/12 mg kit
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Zynrelef (bupivacaine and meloxicam), 400 mg bupivacaine and 12 mg meloxicam single dose application, packaged in a kit, Rx only, Manufactured for Heron Therapeutics, Inc., San Diego, CA, NDC 47426-301-02
- Lots / codes
Lot #: 01126739, Exp 7/31/2023
- Quantity
- 1790 kits
- Company
- Heron Therapeutics, Inc., San Diego, CA
- Distribution
- U.S.A. Nationwide
- Initiated
- August 2, 2022 · Voluntary: Firm initiated
- Classified
- August 12, 2022
- Reported
- August 24, 2022
- Ended
- September 29, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Meloxicam
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.